Metastatic stage IV HER2 positive adenocarcinoma of the stomach or gastro-oesophageal junction Initial PBS Authority application Supporting information form (PB173)

You must lodge this form for a patient starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with trastuzumab for metastatic stage IV Human Epidermal Growth Factor Receptor 2 (HER2) positive adenocarcinoma of the stomach or gastrooesophageal junction.


Page last updated: 5 February 2016

This information was printed Tuesday 27 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.